Validity of the Kinect™ Sensor for Measuring Range of Motion in Patients Post-stroke and Healthy Test Subject

NCT ID: NCT05295654

Last Updated: 2022-10-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-14

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this research is to investigate the validity of the Kinect™ sensor in post-stroke patients and in healthy test subjects during analytic and functional movements. Measurements will be compared with the Vicon-camera system (currently seen as the golden standard).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

STUDY DESIGN

This study is a cross-sectional study in which healthy people and people post stroke will perform 1 session where we will investigate the validity of the Kinect sensor.

MATERIALS

1. The VICON system

The Vicon Camera system is a marker-based system (MBS) to evaluate and analyse movements. Markers are placed on predetermined locations on the skin of the patient according to the Plug in Gait (PIG) full body model. Examination will take place in underwear. A 14-camera infrared opto-electronic video-based motion analysis system with a sample rate of 100 Hz (Vicon MX T40-S, Vicon Motion Systems, Oxford, UK) is used as golden standard. Two synchronized video cameras (Bonita 720C, Vicon, UK) will film the front and side of the participants at a sample rate of 100 Hz.
2. The Kinect system

The Kinect™ system is a markerless-system. It uses a skeleton model to estimate the joint and relative segment orientations. The Kinect-camera will be placed on a tripod at 1,5m height and patients will stand 2m from the camera as recommended by the manufacturer The Kinect™ Azure is the newest version of this system and will be used in this study.

PROCEDURE

All participants will be informed about the study (information document) and a confirmed written informed consent will be obtained by each participant. Baseline demographic and/or clinical characteristics from participants will be obtained by questioning and by searching medical files.

The participant will perform following analytical movements bilateral, both in sitting and standing position:

Hip:

* Hip flexion (standing position): participant lifts one leg in standing position.
* Hip flexion (sitting position): participant lifts one knee as high as possible while seated. The leg can be bend.
* Hip abduction (standing position): participant lifts one leg sidewards as high as possible.
* Hip abduction (sitting position): participant starts with two knees together and then moves one knee outwards as far as possible.
* Hip adduction: patient moves one leg to the other side (in front of the standing leg)

Knee:

* Knee flexion (standing position): participant bends through his/her knees as deep as possible
* Knee flexion (standing position): participant brings one foot towards the butt while maintaining the thigh in the same position
* Knee flexion (sitting position): participant sits on a chair and moves one foot backward (under the chair).
* Knee extension (sitting position): participant sits on a chair and extend his/her knee.

Shoulder:

* Shoulder anteflexion: participant moves the arm upward in front of him/her as high as possible.
* Shoulder abduction (standing position): participant moves the arm upward next to his/her body as high as possible.
* Shoulder adduction: participant moves his/her arm in front of the body to the other side
* Shoulder horizontal adduction: participant lifts his/her arm to an angle of 90° and then moves the arm to the other shoulder (like going to touch the other shoulder with the hand that moves), but the elbow stays extended.

Elbow:

* Elbow flexion in 90° abduction in frontal plane: participant holds the arm in an angle of 90° next to his/her body and moves the hand towards the shoulder while keeping the upper arm in the same position.
* Elbow flexion in 90° anteflexion in sagittal plane: participant holds the arm in an angle of 90° in front of his/her body and moves the hand towards the shoulder while keeping the upper arm in the same position.
* Elbow flexion in 0° abduction: participant needs to bring the hand towards the shoulder in the front of his/her body while keeping the upper arm against the trunk

The following functional movements will be performed:

* Grasping + hand-to-mouth movement: The participant starts with hands next to his/her body. The participant will have to grasp something and bring it to his/her mouth.
* Sit-to-stand: The participant is seated and will have to stand up straight. Afterwards, the participant has to sit down again.
* Touching shoulder with heterolateral hand: The arm of the participant will hang next to his/her body. The participant has to touch the heterolateral shoulder. This will be performed with both sides.

Participants will perform 5 repetitions per movement, with 2 seconds between every repetition. Each side is moved separately.

If necessary, for safety reasons, the participant can use a walking aid to maintain the balance (e.g. rollator, crutch, …).

STATISTICAL ANALYSIS

Statistical analysis will be performed using SPSS version 23 (IBM, Chicago, IL). Significance will be set at 5%. The statistical analysis will be performed by the investigators.

To determine the validity, intraclass correlation coefficients will be calculated. Based on the 95% confidence intervals of the ICC estimates, agreement will be rated poor (less than 0.50), moderate (between 0.50 and 0.75), good (between 0.75 and 0.90) or excellent (greater than 0.90). Mean differences and standard deviations will also be calculated and interpreted.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Kinect validation

Kinect measurements will be compared with the vicon measurements to validate the kinect system.

Group Type EXPERIMENTAL

Kinect validation

Intervention Type OTHER

Participants will perform several movements while both the vicon and kinect are measuring.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Kinect validation

Participants will perform several movements while both the vicon and kinect are measuring.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* People post-stroke or healthy test subjects
* Language: Dutch, English or French
* Age ≥ 18
* Able to sit and stand unsupported for 30 s or more
* Able to stand up from a chair without aid of another person
* Able to signal pain, fear of discomfort
* Able to give informed consent (based on the advice of a medical doctor)
* Able to understand and perform the instructions and to answer questions

Exclusion Criteria

* Concurrent orthopedic and/or musculoskeletal pathologies or disorders that may limit the range of motion (including limb amputations)
* Concurrent neurological disorders (e.g. Parkinson's Disease, Multiple Sclerosis or Amyotrophic Lateral Sclerosis)
* Persons with comorbidity that could hinder the study (e.g. unstable cardiovascular system disorders, lung disorders, severe osteoporosis)
* People with difficulties of speech and/or memory providing that instruction cannot be followed or understood adequate
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vrije Universiteit Brussel

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emma De Keersmaecker

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eva Swinnen, Prof. Ph.D

Role: PRINCIPAL_INVESTIGATOR

Vrije Universiteit Brussel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Brubotics Rehabilitation Research Center

Brussels, , Belgium

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eva Swinnen, Prof. Ph.D

Role: CONTACT

003224774527

Emma De Keersmaecker

Role: CONTACT

003224774527

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Eva Swinnen

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Kinect validity study

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

At-Home Gait Assessment
NCT05724901 COMPLETED